These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 13198750)

  • 1. [Studies on spasmolytics. II. Effect of structural changes in nitrogen-free esters with spasmolytic action; phenylacetic acid and dyphenylacetic acid ester; various derivatives 3,3,5-trimethycyclohexyl-amygdalate (cyclospasmol)].
    FUNCKE AB; ERNSTING MJ; GOOTJES J; REKKER RF; NAUTA WT
    Arzneimittelforschung; 1954 Aug; 4(8):492-4. PubMed ID: 13198750
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on spasmolytics. III. The effect of structural changes in nitrogen-free spasmolytic esters: (a) alpha-chlorophenylacetic acid ester: (b) phenylglyoxylic acid ester].
    FUNCKE AB; REKKER RF; ERNSTING MJ; NAUTA WT
    Arzneimittelforschung; 1956 Feb; 6(2):60-1. PubMed ID: 13315065
    [No Abstract]   [Full Text] [Related]  

  • 3. [Synthesis of spasmolytic alpha-aminoalkyl-alpha-phenylacetic acid esters].
    KLOSA J
    Arch Pharm Ber Dtsch Pharm Ges; 1952; 22(9):401-8. PubMed ID: 13008438
    [No Abstract]   [Full Text] [Related]  

  • 4. Investigation on spasmolytics. VII. The metabolism of 3,5,5-trimethylcyclohexylmandelate (cyclandelate). II.
    ERNSTING MJ; REKKER RF; TERSTEEGE HM; NAUTA WT
    Arzneimittelforschung; 1962 Jun; 12():632-5. PubMed ID: 13890671
    [No Abstract]   [Full Text] [Related]  

  • 5. Investigation into 3.5.5-trimethylcyclohexyl mandelate cyclospasmol.
    EIJKEL G; ERNSTING MJ; REKKER RF; NAUTA WT
    Pharm Weekbl; 1956 May; 91(10):349-58. PubMed ID: 13335486
    [No Abstract]   [Full Text] [Related]  

  • 6. Investigation into 3.5.5-trimethylcyclohexyl mandelate (cyclospasmol).
    EIJKEL G; ERNSTING MJ; REKKER RF; NAUTA WT
    Pharm Weekbl; 1956 Feb; 91(3):81-90. PubMed ID: 13310218
    [No Abstract]   [Full Text] [Related]  

  • 7. Investigation on spasmolytics. VIII. The metabolism of 3,5,5-trimethylcyclohexyl mandelate (Cyclandelate) (III).
    ERNSTING MJ; REKKER RF; TERSTEEGE HM; NAUTA WT
    Arzneimittelforschung; 1962 Jul; 12():691-4. PubMed ID: 13890672
    [No Abstract]   [Full Text] [Related]  

  • 8. Investigation on spasmolytics. IX. The metabolism of 3,5,5-trimethylcyclohexyl mandelate (Cyclandelate). (IV).
    ERNSTING MJ; REKKER RF; TERSTEEGE HM; NAUTA WT
    Arzneimittelforschung; 1962 Aug; 12():853-7. PubMed ID: 13890670
    [No Abstract]   [Full Text] [Related]  

  • 9. Spasmolytic esters of N-substituted alpha-aminophenylacetic acids.
    EDWARDS BK; GOLDBERG AA; WRAGG AH
    J Pharm Pharmacol; 1960 Mar; 12():179-86. PubMed ID: 13819390
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cyclospasmol (mandelic acid ester of 3,5,5-trimethylcyclohexanol) in therapy of skin diseases].
    DOORNINK FJ
    Geneeskd Gids; 1953 Jun; 31(12):247-51. PubMed ID: 13083900
    [No Abstract]   [Full Text] [Related]  

  • 11. The treatment of peripheral vascular diseases with cyclospasmol (mandelic acid ester of 3, 5, 5-trimethylcyclohexanol).
    VAN WIJK TW
    Angiology; 1953 Apr; 4(2):103-13. PubMed ID: 13040814
    [No Abstract]   [Full Text] [Related]  

  • 12. [Studies on spasmolytics. V. Benzilic acid esters].
    FUNCKE AB; REKKER RF; ERNSTING MJ; TERSTEEGE HM; NAUTA WT
    Arzneimittelforschung; 1959 Sep; 9():573-6. PubMed ID: 13825677
    [No Abstract]   [Full Text] [Related]  

  • 13. [Investigations on spasmolytics. I. Pharmacology of mandelic acid esters].
    BROCK N; KUHAS E; LORENZ D
    Arzneimittelforschung; 1952 Apr; 2(4):165-8. PubMed ID: 14944487
    [No Abstract]   [Full Text] [Related]  

  • 14. The spasmolytic properties of thiobenzilic acid esters and related compounds.
    PARKES MW
    Br J Pharmacol Chemother; 1955 Mar; 10(1):95-102. PubMed ID: 14351692
    [No Abstract]   [Full Text] [Related]  

  • 15. [A new group of spasmolytics; esters of mandelic acid].
    BIJLSMA UG
    Arch Ital Sci Farmacol; 1952 Jul; 2(3):226-7. PubMed ID: 13008623
    [No Abstract]   [Full Text] [Related]  

  • 16. [On the pharmacology of a new spasmolytic, the ethyl ester of N-(2-diethylaminoethyl)-2-ethyl-2-phenylmalonamic acid].
    ARRIGONI-MARTELLI E; KRAMER M
    Boll Soc Ital Biol Sper; 1959 Aug; 35():972-4. PubMed ID: 13794502
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pharmacological studies on a new spasmolytic from the dialkvlaminophenylacetamide series with action on the contractility and motility of the uterine muscle].
    GOEBELSMANN U; BELLER FK
    Arzneimittelforschung; 1961 Oct; 11():929-32. PubMed ID: 13899447
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacological studies of n-dimethyl-beta-aminoethyl-diphenylglycolic ester hydrochloride, a new spasmolytic.
    ASTROM A
    Acta Pharmacol Toxicol (Copenh); 1952; 8(4):363-73. PubMed ID: 13016294
    [No Abstract]   [Full Text] [Related]  

  • 19. [Anticholinesterase action of some esters of diethylaminoethanol with spasmolytic action].
    LEVY J
    J Physiol (Paris); 1951; 43(2):235-41. PubMed ID: 14889413
    [No Abstract]   [Full Text] [Related]  

  • 20. [The effect of a new spasmolytic (Avacan) on the coronary vessels].
    BLOMER H; SCHIMERT G
    Dtsch Med Wochenschr; 1951 Apr; 76(14):477-81. PubMed ID: 14831431
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.